65plus: Bariatric and Metabolic Surgery in Patients Over 65 Years of Age
Sponsor
University of Warmia and Mazury in Olsztyn (Other)
Overall Status
Completed
CT.gov ID
NCT06081413
Collaborator
(none)
284
1
7
40.6
Study Details
Study Description
Brief Summary
A retrospective multicenter study that will analyze the results of surgical treatment of obesity in patients over 65 years of age.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
284 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Bariatric and Metabolic Surgery in Patients Over 65 Years of Age - a Multicenter Study
Actual Study Start Date
:
Jun 1, 2022
Actual Primary Completion Date
:
Dec 31, 2022
Actual Study Completion Date
:
Dec 31, 2022
Outcome Measures
Primary Outcome Measures
- weight loss after bariatric surgery [until December 31, 2022]
how much weight patients lost, determined by BMI
- improvement in obesity-related diseases [until December 31, 2022]
changes in the treatment of hypertension and diabetes type 2 - whether the diseases resolved completely or whether there was a change in medications (in accordance with the guidelines of the American Society for Metabolic and Bariatric Surgery ASMBS)
Eligibility Criteria
Criteria
Ages Eligible for Study:
65 Years
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
-
65 years of age and more
-
undergone bariatric surgery
Exclusion Criteria:
- lost to follow up
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | UWM | Olsztyn | Poland | 10-045 |
Sponsors and Collaborators
- University of Warmia and Mazury in Olsztyn
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Natalia Dowgiałło-Gornowicz, MD, PhD,
assistant professor,
University of Warmia and Mazury in Olsztyn
ClinicalTrials.gov Identifier:
NCT06081413
Other Study ID Numbers:
- 38/2023
First Posted:
Oct 13, 2023
Last Update Posted:
Oct 13, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Natalia Dowgiałło-Gornowicz, MD, PhD,
assistant professor,
University of Warmia and Mazury in Olsztyn
Additional relevant MeSH terms: